🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Alzheimer Type Dementia

Longitudinal Profiling of Plasma-Derived Glial Extracellular Vesicles in Alzheimer's Disease NCT07803055NA1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: blood sampling Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Impairment (RAATE-MCI) NCT04956549NA1 site📍 Baton Rouge Pennington Biomedical Research Center · Tests: Physical activity program, Successful Aging Brief Problem-solving Intervention in Different Formats for the Prevention of Suicide in Adults Over 50 NCT06338904NA1 site📍 Santiago de Compostela University of Santiago de Compostela · Tests: Problem-solving-based psychological intervention DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau NCT07142278Phase 11 site📍 Miami Lakes Nuravax, Inc. · Tests: DUVAX 200 µg, DUVAX 400 µg, Placebo (Adjuvant only) Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline NCT05907343NA1 site📍 Austin University of Texas at Austin · Tests: Closed-loop TBS, Open-loop TBS Effect of CAFfeine on Cognition in Alzheimer's Disease NCT04570085Phase 317 sites📍 Amiens📍 Arras📍 Beauvais University Hospital, Lille · Tests: Caffeine, Placebo Fundus Camera Module for Early Detection of Alzheimer's Disease NCT06841848n/a1 site📍 Rome I.R.C.C.S. Fondazione Santa Lucia · Tests: Fundoscopic Exam Digital Solutions for Predicting the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk Factors NCT07731191NA2 sites📍 Brescia📍 Brescia IRCCS Centro San Giovanni di Dio Fatebenefratelli · Tests: Digital solution for the prediction of the biological mechanisms of Alzheimer's disease through the analysis of ri… Neurocognitive Assessment Platform 4 Alzheimer NCT07272811n/a1 site📍 Milan IRCCS San Raffaele Transcranial Random Noise (tRNS) for BPSD in Alzheimer's Disease: A Double-blind Randomized Controlled Trial NCT07827196NA1 site📍 Hefei Anhui Medical University · Tests: High frequency transcranial random noise, Sham high frequency transcranial random noise PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620 NCT05456503Phase 31 site📍 Philadelphia University of Pennsylvania · Tests: [18F]-PI-2620 Positive Psychology for Early Cognitive Decline: Effects on Cognitive and Brain Function NCT07289061NA1 site📍 Thessaloniki Aristotle University Of Thessaloniki · Tests: Positive Psychology Intervention, Treatment as usual (TAU) Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging NCT07202494n/a1 site📍 Marseille Assistance Publique Hopitaux De Marseille · Tests: Imaging Techniques (MRI 3T & 7T, Functional, Structural, and Metabolic Imaging) PUMCH Dementia Longitudinal Cohort Study NCT05023564n/a1 site📍 Beijing Peking Union Medical College Hospital Caring for Caregivers of Individuals With Alzheimer's Disease NCT07486037NA1 site📍 Indianapolis Indiana University · Tests: Exercise Development of an Outcome Score for Patients With Knee Osteoarthritis and Knee Joint Endoprosthesis Using an App NCT07212699NA1 site📍 Munich Technical University of Munich · Tests: KneeApp A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1) NCT05511363Phase 3129 sites📍 Homewood📍 Phoenix📍 Encino Karuna Therapeutics, Inc., a Bristol Myers Squibb company · Tests: KarXT, Placebo Neuropsychological Profiles and Musical Engagement in Parkinson's and Alzheimer's Disease NCT06688968NA3 sites📍 Montpellier📍 Montpellier📍 Montpellier University Hospital, Montpellier · Tests: neuropsychologist interview, questionnaire Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia NCT06511752EARLY Phase 11 site📍 Austin University of Texas at Austin · Tests: Psychosocial educational, support group and implementation of strategies Biomarkers for Monitoring Dementia Progression NCT06855368n/a2 sites📍 Roma📍 Sassari IRCCS San Raffaele Roma Exercise to Improve Brain Health in Older African Americans NCT05597124Phase 21 site📍 Newark Rutgers, The State University of New Jersey · Tests: Cardio-Dance Fitness, Strength, Flexibility & Balance Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease NCT05924425Phase 41 site📍 Montpellier University Hospital, Montpellier · Tests: Daridorexant 50 mg, Placebo, Polysomnography, Neuropsychological assessment, Questionnaires on sleep and behavioural pr… Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD) NCT06362707Phase 26 sites📍 Tromsø📍 Oslo📍 Haugesund Helse Stavanger HF · Tests: Fasudil, Placebo I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms NCT05733520NA2 sites📍 Indianapolis📍 Indianapolis Indiana University · Tests: Brain CareNotes, Dementia Guide Expert Early Detection of Alzheimer's Disease and Affective Disorders by Automated Voice and Speech Analysis (PLATA) NCT05943834n/a1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: Series of cognitive tasks during a semi-automated call Clinical Cohort of Memory Disorders NCT07880275n/a1 site📍 Seoul Yonsei University Study to Understand Novel Biomarkers in Researching Dementia NCT06547099n/a1 site📍 St Louis Washington University School of Medicine · Tests: Clinical tau PET, Clinical amyloid test, Research blood collection, Cognitive assessments Exploratory Study of Low-Dose Whole-Brain Radiation Therapy With HeLaXON 1X in Patients With Mild Alzheimer's Disease Dementia NCT07863011NA1 site📍 Cheonan ReadyCure Inc. · Tests: HeLaXON 1X Low-Dose Radiation Therapy, Sham HeLaXON 1X Procedure Biomarkers of Synaptic Damage in Multiple Sclerosis NCT03217396n/a1 site📍 Pozzilli Neuromed IRCCS · Tests: lumbar puncture Levetiracetam for Persons at Risk for Alzheimer's Disease NCT07477431Phase 22 sites📍 Toronto📍 Toronto Sunnybrook Health Sciences Centre · Tests: Levetiracetam (LEV), Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy